Iatrogenic Alzheimer's disease in recipients of cadaveric pituitary-derived growth hormone.

"Competing interests J.C. is a shareholder and director of D-Gen, Ltd., an academic spin-out company working in the field of prion disease diagnosis, decontamination and therapeutics. D-Gen supplied the ICSM35 antibody used for PrP immunohistochemistry. The other authors declare no competing interests."

"https://doi.org/10.13039/501100000272DH | National Institute for Health Research (NIHR); The MRC Prion Unit is core-funded by the UK Medical Research Council. The clinical research activities of the National Prion Clinic are supported by the National Institute of Health Research (NIHR) UCLH Biomedical Research Centre.; https://doi.org/10.13039/501100000272DH | National Institute for Health Research (NIHR); https://doi.org/10.13039/501100000364Stroke Association; https://doi.org/10.13039/501100002283Alzheimer’s Research UK (ARUK)"